Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy
Sponsor: University Health Network, Toronto
This observational or N/A phase trial investigates Advanced Cancer and Immunotherapy and is currently completed. University Health Network, Toronto leads this study, which shows 18 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
18 versions recorded-
Mar 2026 — Present [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2025 — Mar 2026 [monthly]
Active Not Recruiting
-
Mar 2025 — Apr 2025 [monthly]
Active Not Recruiting
-
Sep 2024 — Mar 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
▶ Show 13 earlier versions
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting
-
Nov 2023 — Apr 2024 [monthly]
Active Not Recruiting
-
Jun 2023 — Nov 2023 [monthly]
Active Not Recruiting
-
Nov 2022 — Jun 2023 [monthly]
Active Not Recruiting
-
Nov 2021 — Nov 2022 [monthly]
Active Not Recruiting
-
May 2021 — Nov 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Jul 2020 — Jan 2021 [monthly]
Recruiting
-
May 2019 — Jul 2020 [monthly]
Recruiting
-
Jun 2018 — May 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Dec 2017 [monthly]
Not Yet Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .